U.S. NeuroSurgical Holdings, Inc. (USNU)
USD 0.82
(-8.38%)
USD 0.82
(-8.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -49 Thousand USD | 96.59% |
| 2022 | -1.49 Million USD | -189.53% |
| 2021 | -515 Thousand USD | -156.39% |
| 2020 | 915 Thousand USD | 232.73% |
| 2019 | 275 Thousand USD | -76.0% |
| 2018 | 131 Thousand USD | -33.72% |
| 2017 | 1.84 Million USD | -23.6% |
| 2016 | 2.07 Million USD | 28.29% |
| 2015 | 1.79 Million USD | 24.05% |
| 2014 | 1.4 Million USD | 240.24% |
| 2013 | -1.01 Million USD | -244.44% |
| 2012 | 1.71 Million USD | -24.35% |
| 2011 | 928 Thousand USD | -29.54% |
| 2010 | 1.77 Million USD | 7.33% |
| 2009 | 1.22 Million USD | 74.29% |
| 2008 | 704 Thousand USD | 486.81% |
| 2007 | - USD | -121.82% |
| 2006 | 860 Thousand USD | 58.25% |
| 2005 | 527 Thousand USD | -34.53% |
| 2004 | 805 Thousand USD | -18.85% |
| 2003 | 992 Thousand USD | -19.68% |
| 2002 | 1.23 Million USD | -4.04% |
| 2001 | 1.28 Million USD | -0.85% |
| 2000 | 1.29 Million USD | -22.92% |
| 1999 | 1.68 Million USD | 993.51% |
| 1998 | 154 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -471 Thousand USD | -93.0% |
| 2024 Q2 | -431 Thousand USD | 8.53% |
| 2023 Q2 | -232 Thousand USD | -93.33% |
| 2023 FY | - USD | 50.13% |
| 2023 Q1 | -120 Thousand USD | -118.69% |
| 2023 Q3 | -149 Thousand USD | 35.78% |
| 2023 Q4 | -243 Thousand USD | -63.09% |
| 2022 FY | - USD | -189.53% |
| 2022 Q3 | -367 Thousand USD | 71.35% |
| 2022 Q2 | -1.28 Million USD | -165.22% |
| 2022 Q1 | -483 Thousand USD | -30.89% |
| 2022 Q4 | 642 Thousand USD | 274.93% |
| 2021 Q2 | -375 Thousand USD | -167.69% |
| 2021 Q1 | 554 Thousand USD | 65.87% |
| 2021 FY | - USD | -156.39% |
| 2021 Q3 | -327 Thousand USD | 12.8% |
| 2021 Q4 | -369 Thousand USD | -12.84% |
| 2020 Q4 | 334 Thousand USD | 32.02% |
| 2020 FY | - USD | 232.73% |
| 2020 Q3 | 253 Thousand USD | 237.33% |
| 2020 Q1 | 252 Thousand USD | 248.24% |
| 2020 Q2 | 75 Thousand USD | -70.24% |
| 2019 Q1 | 300 Thousand USD | 137.41% |
| 2019 Q4 | -170 Thousand USD | -186.73% |
| 2019 Q2 | -51 Thousand USD | -117.0% |
| 2019 Q3 | 196 Thousand USD | 484.31% |
| 2019 FY | - USD | -76.0% |
| 2018 Q3 | 337 Thousand USD | -30.23% |
| 2018 FY | - USD | -33.72% |
| 2018 Q4 | -802 Thousand USD | -337.98% |
| 2018 Q1 | 465 Thousand USD | 304.35% |
| 2018 Q2 | 483 Thousand USD | 3.87% |
| 2017 Q4 | 115 Thousand USD | -67.51% |
| 2017 Q1 | 715 Thousand USD | 13.49% |
| 2017 Q3 | 354 Thousand USD | -35.05% |
| 2017 Q2 | 545 Thousand USD | -23.78% |
| 2017 FY | - USD | -23.6% |
| 2016 Q1 | 588 Thousand USD | -2.81% |
| 2016 Q4 | 630 Thousand USD | 28.57% |
| 2016 FY | - USD | 28.29% |
| 2016 Q3 | 490 Thousand USD | -11.71% |
| 2016 Q2 | 555 Thousand USD | -5.61% |
| 2015 Q1 | 407 Thousand USD | -26.8% |
| 2015 Q4 | 605 Thousand USD | 38.13% |
| 2015 Q3 | 438 Thousand USD | 45.51% |
| 2015 FY | - USD | 24.05% |
| 2015 Q2 | 301 Thousand USD | -26.04% |
| 2014 Q2 | 251 Thousand USD | 184.23% |
| 2014 Q3 | 716 Thousand USD | 185.26% |
| 2014 Q4 | 556 Thousand USD | -22.35% |
| 2014 FY | - USD | 240.24% |
| 2014 Q1 | -298 Thousand USD | 4.18% |
| 2013 Q3 | -177 Thousand USD | 41.0% |
| 2013 FY | - USD | -244.44% |
| 2013 Q2 | -300 Thousand USD | -37.61% |
| 2013 Q1 | -218 Thousand USD | -972.0% |
| 2013 Q4 | -311 Thousand USD | -75.71% |
| 2012 Q3 | 279 Thousand USD | 73.29% |
| 2012 Q4 | 25 Thousand USD | -91.04% |
| 2012 Q1 | 239 Thousand USD | 22.56% |
| 2012 FY | - USD | -24.35% |
| 2012 Q2 | 161 Thousand USD | -32.64% |
| 2011 Q4 | 195 Thousand USD | 96.97% |
| 2011 Q2 | 255 Thousand USD | -32.54% |
| 2011 Q1 | 378 Thousand USD | -56.25% |
| 2011 Q3 | 99 Thousand USD | -61.18% |
| 2011 FY | - USD | -29.54% |
| 2010 Q2 | -201 Thousand USD | -177.31% |
| 2010 Q3 | 394 Thousand USD | 296.02% |
| 2010 Q4 | 864 Thousand USD | 119.29% |
| 2010 FY | - USD | 7.33% |
| 2010 Q1 | 260 Thousand USD | -17.98% |
| 2009 Q3 | 379 Thousand USD | -10.61% |
| 2009 Q2 | 424 Thousand USD | 300.0% |
| 2009 Q1 | 106 Thousand USD | 6.0% |
| 2009 FY | - USD | 74.29% |
| 2009 Q4 | 317 Thousand USD | -16.36% |
| 2008 Q1 | 223 Thousand USD | 7333.33% |
| 2008 Q4 | 100 Thousand USD | -58.33% |
| 2008 FY | - USD | 486.81% |
| 2008 Q2 | 141 Thousand USD | -36.77% |
| 2008 Q3 | 240 Thousand USD | 70.21% |
| 2007 Q1 | 90 Thousand USD | -83.27% |
| 2007 Q4 | 3000.00 USD | -98.38% |
| 2007 Q3 | 185 Thousand USD | 825.0% |
| 2007 Q2 | 20 Thousand USD | -77.78% |
| 2007 FY | - USD | -121.82% |
| 2006 Q1 | 109 Thousand USD | 22.47% |
| 2006 Q3 | 708 Thousand USD | 362.75% |
| 2006 Q4 | 538 Thousand USD | -24.01% |
| 2006 FY | - USD | 58.25% |
| 2006 Q2 | 153 Thousand USD | 40.37% |
| 2005 FY | - USD | -34.53% |
| 2005 Q3 | 207 Thousand USD | -0.96% |
| 2005 Q4 | 89 Thousand USD | -57.0% |
| 2005 Q2 | 209 Thousand USD | 850.0% |
| 2005 Q1 | 22 Thousand USD | -68.57% |
| 2004 FY | - USD | -18.85% |
| 2004 Q3 | 204 Thousand USD | -44.72% |
| 2004 Q1 | 137 Thousand USD | -45.2% |
| 2004 Q2 | 369 Thousand USD | 169.34% |
| 2004 Q4 | 70 Thousand USD | -65.69% |
| 2003 Q3 | 92 Thousand USD | -46.51% |
| 2003 FY | - USD | -19.68% |
| 2003 Q1 | 479 Thousand USD | 107.36% |
| 2003 Q4 | 250 Thousand USD | 171.74% |
| 2003 Q2 | 172 Thousand USD | -64.09% |
| 2002 Q3 | 288 Thousand USD | -2.04% |
| 2002 Q4 | 231 Thousand USD | -19.79% |
| 2002 FY | - USD | -4.04% |
| 2002 Q1 | 422 Thousand USD | 31.46% |
| 2002 Q2 | 294 Thousand USD | -30.33% |
| 2001 Q3 | 350 Thousand USD | -16.07% |
| 2001 Q2 | 417 Thousand USD | 109.55% |
| 2001 Q1 | 199 Thousand USD | -46.79% |
| 2001 FY | - USD | -0.85% |
| 2001 Q4 | 321 Thousand USD | -8.29% |
| 2000 Q4 | 374 Thousand USD | 59.83% |
| 2000 FY | - USD | -22.92% |
| 2000 Q3 | 234 Thousand USD | 96.64% |
| 2000 Q2 | 119 Thousand USD | 0.0% |
| 1999 Q4 | 121 Thousand USD | -73.7% |
| 1999 Q2 | 155 Thousand USD | 0.0% |
| 1999 FY | - USD | 993.51% |
| 1999 Q3 | 460 Thousand USD | 196.77% |
| 1998 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 99.554% |
| Arem Pacific Corporation | 36.71 Thousand USD | 233.46% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 56.603% |
| BioCorRx Inc. | -2.68 Million USD | 98.174% |
| Bionik Laboratories Corp. | -4.77 Million USD | 98.974% |
| Banyan Corp. | 583.94 Thousand USD | 108.391% |
| Clearday, Inc. | -7.53 Million USD | 99.35% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | 480.642% |
| Quantum Medical Transport, Inc. | - USD | Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 95.497% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 97.783% |
| Selectis Health, Inc. | -7.29 Million USD | 99.328% |
| Ethema Health Corporation | 2.07 Million USD | 102.365% |
| HealthLynked Corp. | -2.75 Million USD | 98.218% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 98.154% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | 269.868% |
| Comjoyful International Company | 167.89 Thousand USD | 129.185% |
| Medical Facilities Corporation | 77.94 Million USD | 100.063% |
| MedSmart Group Inc. | 47.8 Thousand USD | 202.491% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 92.139% |
| Nova Leap Health Corp. | 994.46 Thousand USD | 104.927% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 75.71% |
| PAO Group, Inc. | 292.96 Thousand USD | 116.726% |
| Primemd Inc. | 3.42 Million USD | 101.43% |
| Raffles Medical Group Ltd | 100.7 Million USD | 100.049% |
| Ryman Healthcare Limited | -54.51 Million USD | 99.91% |
| Stem Cell Authority, Ltd. | -4233.00 USD | -1057.571% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 98.307% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 91.179% |
| Veltex Corporation | -938.45 Thousand USD | 94.779% |
| World Financial Holding Group | -28.43 Thousand USD | -72.353% |
| Xcelerate Inc. | -2.53 Million USD | 98.07% |